Evidence map›Paper›PMID 29683789›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

DNA Repair Deficiency and Immunotherapy Response.

Kent W Mouw, Alan D D'Andrea

Abstract readComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Inherited genetic risk factors in young-onset lung cancer.medRxiv : the preprint server for health sciences · 2026
    Article
  2. Review
  3. Article
  4. ER-positive and BRCA2-mutated breast cancer: a literature review.European journal of medical research · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Molecular Pathology of Urothelial Carcinoma.Surgical pathology clinics · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Kent W MouwKent W. Mouw, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA; and Alan D. D'Andrea, Dana-Farber Cancer Institute, Boston, MA.
Alan D D'AndreaKent W. Mouw, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA; and Alan D. D'Andrea, Dana-Farber Cancer Institute, Boston, MA.

Funding

Investigating the effect of ERCC2 mutations on DNA repair capacity and chemo-radiotherapy response in muscle-invasive bladder cancerK08CA219504 · NCI · DANA-FARBER CANCER INST · PI MOUW, KENT W · 2017 to 2021
$885k
NCI NIH HHS K08 CA219504
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DNA Repair-Deficiency DisordersNeoplasmsB7-H1 AntigenDNA DamageHumansImmunotherapyProgrammed Cell Death 1 ReceptorB7-H1 AntigenProgrammed Cell Death 1 Receptor

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.